Efficacy of virtual reality exposure therapy combined with two pharmacotherapies in the treatment of agoraphobia
Fiche du document
2011
- handle: 10670/1.gonwxd
- 1697-2600
Ce document est lié à :
http://www.redalyc.org/revista.oa
International Journal of Clinical and Health Psychology
Mots-clés
Psicología Agoraphobia Virtual reality Experimental study Pharmacological treatment Cognitive behavioral treatmentSujets proches
TherapyCiter ce document
Marién González Lorenzo et al., « Efficacy of virtual reality exposure therapy combined with two pharmacotherapies in the treatment of agoraphobia », International Journal of Clinical and Health Psychology, ID : 10670/1.gonwxd
Métriques
Partage / Export
Résumé
"Currently, some psychopharmacological treatments, cognitivebehavioral therapies (CBT), and a combination of both are considered effective treatments for agoraphobia. Among psychological treatments, new therapeutic alternatives such as virtual reality exposure treatment (VRET) have been developed. The aim of this experimental study was to evaluate the efficacy of VRET combined with two antidepressant drugs (venlafaxine and paroxetine) in a sample of agoraphobia patients (N = 64), using a virtual system consisting of seven scenarios.Five types of treatment were compared: four combined treatment groups and one psychopharmacological treatment. Measures were taken at pre-treatment, posttreatment, and six-month follow-up; agoraphobia and anxiety measures were used as dependent variables. Results showed that all groups were statistically effective, both at post-treatment and six-month follow-up. However, based on clinical efficacy, results showed that combined treatment groups including VRET appeared to be better than traditional techniques at decreasing agoraphobia and anxiety measures and keeping them lower over time."